NCT03702621View on ClinicalTrials.gov

Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Colorectal Surgery
Interventions
DRUG

liposomal Bupivacaine

20 mL liposomal bupivacaine are injected into the liposomal bupivacaine group

DRUG

Bupivacaine Hydrochloride

"40 mL of 0.125% bupivacaine hydrochloride are injected into the liposomal bupivacaine group.~60mL of 0.25% bupivacaine hydrochloride are injected into the standard bupivacaine group"

Trial Locations (1)

46202

Indiana University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03702621 - Comparing Liposomal Bupivacaine Versus Standard Bupivacaine in Colorectal Surgery | Biotech Hunter | Biotech Hunter